Market Overview:
The global Crispr genomic cure market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for gene editing and CRISPR-based therapies, rising prevalence of genetic disorders, and growing investments in R&D activities. The Crispr genomic cure market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into gRNA design and vector construction, cell line and engineering, others. On the basis of application, the market is segmented into biomedical applications such as cancer therapy & prevention; pharmaceuticals such as monoclonal antibodies; agricultural applications such as plant breeding & crop protection; and others including food processing & diagnostics. The biomedical sector dominates this market with a share of XX%.
Product Definition:
The Crispr Genomic Cure is a technique that is used to treat diseases by editing the patients’ genes. The importance of Crispr Genomic Cure is that it can be used to treat many different diseases, including cancer.
gRNA Design and Vector Construction:
gRNA Design and Vector Construction, it's usage and growth factor in Crispr Genomic Cure market is a research study that presents an analysis of the current trends in the Crispr/Cas9 genetic scissors market. The study aims at providing insights into future opportunities for this technology across different application areas.
Cell Line and Engineering:
The global Crispr (Cell Line and Engineering) market is expected to witness significant growth over the forecast period. The major factor that propels the growth of this industry is its application in genetic engineering for curing incurable diseases such as cancer, HIV, etc. It works by modifying & correcting DNA sequence which results into permanent cure with no side effects unlike other drugs or therapies available for disease treatment.
Application Insights:
The biomedical application segment dominated the global Crispr genomic cure market in terms of revenue share in 2017. This is due to its wide applications such as gene therapy, stem cell research, and others. The rising number of clinical trials for various diseases conducted using crispr genome engineering tools are also contributing to the growth of this segment.
Pharmaceutical was the second largest application segment that accounted for over 15% revenue share in 2017 owing to growing R&D activities pertaining to new drug development and other therapeutic applications using crispr genome editing tools. Several companies including Intellia Therapeutics, Inc.,Editas Medicine Ltd.,and CRISPR Pharmaceuticals have obtained U.
Regional Analysis:
North America dominated the global Crispr genomic cure market in terms of revenue share in 2016. This is due to the presence of a large number of CRISPR-Cas9 based companies, such as Intellia Therapeutics, andamericine genomics, along with government support for R&D activities related to genome editing. The U.S.
The Asia Pacific region on account of growing awareness pertaining to genome editing technologies are expected to grow at fastest rate during the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases: The Crispr Genomic Cure market is expected to benefit from the increasing prevalence of chronic diseases such as cancer, diabetes, and heart disease. This is because Crispr genomic cures can help in the early diagnosis and treatment of these diseases.
- Rising demand for personalized medicine: There is a growing demand for personalized medicine across the world. This is because every individual has a unique genetic makeup that requires specific treatments. Crispr genomic cures can help in the development of customized therapies for patients based on their genetic profiles.
- Advances in gene editing technology: The Crispr Genomic Cure market is expected to benefit from advances in gene editing technology. This technology allows scientists to edit genes with precision and accuracy, thus helping them develop new therapies and treatments for various diseases.
Scope Of The Report
Report Attributes
Report Details
Report Title
Crispr Genomic Cure Market Research Report
By Type
gRNA Design and Vector Construction, Cell Line and Engineering, Others
By Application
Biomedical, Pharmaceutical, Agricultural, Others
By Companies
Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, Intellia Therapeutics, Merck KGaA, New England Biolabs, Precision BioSciences, Sangamo Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Crispr Genomic Cure Market Report Segments:
The global Crispr Genomic Cure market is segmented on the basis of:
Types
gRNA Design and Vector Construction, Cell Line and Engineering, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biomedical, Pharmaceutical, Agricultural, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Applied StemCel
- Beam Therapeutics
- CALYXT
- Cellecta
- Cellectis
- CRISPR Therapeutics AG
- Editas Medicine
- ERS Genomics
- Integrated DNA Technologies
- Intellia Therapeutics
- Merck KGaA
- New England Biolabs
- Precision BioSciences
- Sangamo Therapeutics
Highlights of The Crispr Genomic Cure Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- gRNA Design and Vector Construction
- Cell Line and Engineering
- Others
- By Application:
- Biomedical
- Pharmaceutical
- Agricultural
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Crispr Genomic Cure Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Crispr is a gene editing tool that can be used to cure genetic diseases.
Some of the major players in the crispr genomic cure market are Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, Intellia Therapeutics, Merck KGaA, New England Biolabs, Precision BioSciences, Sangamo Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Crispr Genomic Cure Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Crispr Genomic Cure Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Crispr Genomic Cure Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Crispr Genomic Cure Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Crispr Genomic Cure Market Size & Forecast, 2018-2028
4.5.1 Crispr Genomic Cure Market Size and Y-o-Y Growth
4.5.2 Crispr Genomic Cure Market Absolute $ Opportunity
Chapter 5 Global Crispr Genomic Cure Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Crispr Genomic Cure Market Size Forecast by Type
5.2.1 gRNA Design and Vector Construction
5.2.2 Cell Line and Engineering
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Crispr Genomic Cure Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Crispr Genomic Cure Market Size Forecast by Applications
6.2.1 Biomedical
6.2.2 Pharmaceutical
6.2.3 Agricultural
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Crispr Genomic Cure Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Crispr Genomic Cure Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Crispr Genomic Cure Analysis and Forecast
9.1 Introduction
9.2 North America Crispr Genomic Cure Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Crispr Genomic Cure Market Size Forecast by Type
9.6.1 gRNA Design and Vector Construction
9.6.2 Cell Line and Engineering
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Crispr Genomic Cure Market Size Forecast by Applications
9.10.1 Biomedical
9.10.2 Pharmaceutical
9.10.3 Agricultural
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Crispr Genomic Cure Analysis and Forecast
10.1 Introduction
10.2 Europe Crispr Genomic Cure Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Crispr Genomic Cure Market Size Forecast by Type
10.6.1 gRNA Design and Vector Construction
10.6.2 Cell Line and Engineering
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Crispr Genomic Cure Market Size Forecast by Applications
10.10.1 Biomedical
10.10.2 Pharmaceutical
10.10.3 Agricultural
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Crispr Genomic Cure Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Crispr Genomic Cure Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Crispr Genomic Cure Market Size Forecast by Type
11.6.1 gRNA Design and Vector Construction
11.6.2 Cell Line and Engineering
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Crispr Genomic Cure Market Size Forecast by Applications
11.10.1 Biomedical
11.10.2 Pharmaceutical
11.10.3 Agricultural
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Crispr Genomic Cure Analysis and Forecast
12.1 Introduction
12.2 Latin America Crispr Genomic Cure Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Crispr Genomic Cure Market Size Forecast by Type
12.6.1 gRNA Design and Vector Construction
12.6.2 Cell Line and Engineering
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Crispr Genomic Cure Market Size Forecast by Applications
12.10.1 Biomedical
12.10.2 Pharmaceutical
12.10.3 Agricultural
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Crispr Genomic Cure Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Crispr Genomic Cure Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Crispr Genomic Cure Market Size Forecast by Type
13.6.1 gRNA Design and Vector Construction
13.6.2 Cell Line and Engineering
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Crispr Genomic Cure Market Size Forecast by Applications
13.10.1 Biomedical
13.10.2 Pharmaceutical
13.10.3 Agricultural
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Crispr Genomic Cure Market: Competitive Dashboard
14.2 Global Crispr Genomic Cure Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Applied StemCel
14.3.3 Beam Therapeutics
14.3.4 CALYXT
14.3.5 Cellecta
14.3.6 Cellectis
14.3.7 CRISPR Therapeutics AG
14.3.8 Editas Medicine
14.3.9 ERS Genomics
14.3.10 Integrated DNA Technologies
14.3.11 Intellia Therapeutics
14.3.12 Merck KGaA
14.3.13 New England Biolabs
14.3.14 Precision BioSciences
14.3.15 Sangamo Therapeutics
